Hepatitis B Virus: From Diagnosis to Treatment

被引:52
|
作者
Guvenir, Meryem [1 ]
Arikan, Ayse [2 ,3 ]
机构
[1] Near East Univ, Vocat Sch Hlth Serv, Nicosia, Northern Cyprus, Turkey
[2] Near East Univ, Dept Med Microbiol, Fac Med, Nicosia, Northern Cyprus, Turkey
[3] Near East Univ, DESAM Inst, Nicosia, Northern Cyprus, Turkey
关键词
hepatitis B virus (HBV); serology; nucleic acid testing; antiviral treatment; TENOFOVIR ALAFENAMIDE; THERAPY; HBEAG; MUTATIONS; IDENTIFICATION; EPIDEMIOLOGY; REACTIVATION; LAMIVUDINE; INFECTION; UPDATE;
D O I
10.33073/pjm-2020-044
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hepatitis B infection is still a global concern progressing as acute-chronic hepatitis, severe liver failure, and death. The infection is most widely transmitted from the infected mother to a child, with infected blood and body fluids. Pregnant women, adolescents, and all adults at high risk of chronic infection are recommended to be screened for hepatitis B infection. The initial analysis includes serological tests that allow differentiation of acute and chronic hepatitis. Molecular assays performed provide detection and quantification of viral DNA, genotyping, drug resistance, and precore/core mutation analysis to confirm infection and monitor disease progression in chronic hepatitis B patients. All patients with chronic hepatitis B should be treated with antiviral medications and regularly monitored for efficient treatment. The current treatment Is based on nucleos(t)ide analogs and pegylated interferons that save lives by decreasing liver cancer death, liver transplant, slow or reverse the progression of liver disease as well as the virus infectivity.
引用
收藏
页码:391 / 399
页数:9
相关论文
共 50 条
  • [31] A PCR-RFLP based protocol for the detection of hepatitis B virus variants in some lamivudine-untreated chronic hepatitis B virus carriers in Pakistan
    Tauseef, Isfahan
    Iqbal, Furhan
    Rehman, Wajid
    Ali, Muhammad
    Qureshi, Javed Anver
    Aslam, Muhammad Assad
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 25 (02) : 349 - 352
  • [32] Escape mutants of hepatitis B virus
    Mario Jaramillo, Carlos
    Navas, Maria-Cristina
    REVISTA CHILENA DE INFECTOLOGIA, 2015, 32 (02): : 190 - 197
  • [33] The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis
    Liu, Jun-Ying
    Sheng, Yun-Jian
    Hu, Huai-Dong
    Zhong, Qing
    Wang, Jing
    Tong, Shi-Wen
    Zhou, Zhi
    Zhang, Da-Zhi
    Hu, Peng
    Ren, Hong
    VIROLOGY JOURNAL, 2012, 9
  • [34] Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment
    Kobayashi, Mariko
    Suzuki, Fumitaka
    Akuta, Norio
    Yatsuji, Hiromi
    Hosaka, Tetsuya
    Sezaki, Hitomi
    Kobayashi, Masahiro
    Kawamura, Yusuke
    Suzuki, Yoshiyuki
    Arase, Yasuji
    Ikeda, Kenji
    Mineta, Rie
    Iwasaki, Satomi
    Watahiki, Sachiyo
    Kumada, Hiromitsu
    HEPATOLOGY RESEARCH, 2010, 40 (02) : 125 - 134
  • [35] Hepatitis C: From diagnosis to global virus elimination
    Schmitt, Annika
    Sarrazin, Christoph
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (16) : 955 - 961
  • [36] Improving testing for hepatitis B before treatment with rituximab
    Dyson, Jessica K.
    Jopson, Laura
    Ng, Sarah
    Lowery, Matthew
    Harwood, Jayne
    Waugh, Sheila
    Valappil, Manoj
    McPherson, Stuart
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (10) : 1172 - 1178
  • [37] Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation
    Liu, Jonathan
    Goicochea, Pedro
    Block, Timothy
    Brosgart, Carol L.
    Donaldson, Eric F.
    Lenz, Oliver
    Lim, Seng Gee
    Marins, Ed G.
    Mishra, Poonam
    Peters, Marion G.
    Miller, Veronica
    JOURNAL OF VIRUS ERADICATION, 2017, 3 (01) : 1 - 6
  • [38] Genetic diversity of hepatitis B virus and hepatitis C virus in human immunodeficiency virus type 1-co-infected patients from Venezuela
    Jaspe, Rossana C.
    Sulbaran, Yoneira F.
    Loureiro, Carmen L.
    Martinez, Nahir
    Devesa, Marisol
    Rodriguez, Yesseima
    Torres, Jaime R.
    Rangel, Hector R.
    Pujol, Flor H.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2014, 63 : 1099 - 1104
  • [39] Acute hepatitis B infection associated with drug-resistant hepatitis B virus
    Xu, Zhihui
    Liu, Yan
    Xu, Teng
    Chen, Li
    Si, Lanlan
    Wang, Yao
    Ren, Xiaoqiang
    Zhong, Yanwei
    Zhao, Jingmin
    Xu, Dongping
    JOURNAL OF CLINICAL VIROLOGY, 2010, 48 (04) : 270 - 274
  • [40] The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection
    Buster, E. H. C. J.
    Baak, B. C.
    Bakker, C. M.
    Beuers, U. H. W.
    Brouwer, J. T.
    Drenth, J. P. H.
    van Erpecum, K. J.
    van Hoek, B.
    Honkoop, P.
    Kerbert-Dreteler, M. J.
    Koek, G. H.
    van Nieuwkerk, K. M. J.
    van Soest, H.
    van der Spek, B. W.
    Tan, A. C. I. T. L.
    Vrolijk, J. M.
    Janssen, H. L. A.
    NETHERLANDS JOURNAL OF MEDICINE, 2012, 70 (08) : 381 - 385